Cargando…
Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms
SIMPLE SUMMARY: Neuroendocrine tumors of the gastrointestinal tract (GEP-NEN) are a rare type of tumor with considerable variability in the course of disease, which makes clinical management particularly challenging. Biomarkers that are able to guide personalized treatment decisions would be of impo...
Autores principales: | Detjen, Katharina M., Otto, Raik, Giesecke, Yvonne, Geisler, Lukas, Riemer, Pamela, Jann, Henning, Grötzinger, Carsten, Sers, Christine, Pascher, Andreas, Lüdde, Tom, Leser, Ulf, Wiedenmann, Bertram, Sigal, Michael, Tacke, Frank, Roderburg, Christoph, Hammerich, Linda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8430927/ https://www.ncbi.nlm.nih.gov/pubmed/34503273 http://dx.doi.org/10.3390/cancers13174463 |
Ejemplares similares
-
Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics
por: Otto, Raik, et al.
Publicado: (2023) -
Osteopontin is a prognostic circulating biomarker in patients with neuroendocrine neoplasms
por: Kidess, Evelyn, et al.
Publicado: (2023) -
Primary Neuroendocrine Neoplasms of the Breast: Case Series and Literature Review
por: Özdirik, Burcin, et al.
Publicado: (2020) -
Nuclear survivin is a prognosticator in gastroenteropancreatic neuroendocrine neoplasms: a meta-analysis
por: Krieg, Sarah, et al.
Publicado: (2022) -
Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine Neoplasms
por: Mafficini, Andrea, et al.
Publicado: (2019)